Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen Sidransky

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Expert Opinion on Therapeutic Targets|February 29, 2020
Glucocerebrosidase as a therapeutic target for Parkinson's diseaseYu Chen, Richard Sam, Pankaj Sharma, et al.
Pediatrics|April 2, 2009
Lysosomal storage disorders in the newbornOrna Staretz-Chacham, Tess C Lang, Mary E LaMarca, et al.
Biochemistry|September 28, 2013
Saposin C protects glucocerebrosidase against α-synuclein inhibitionThai Leong Yap, James M Gruschus, Arash Velayati, et al.
Archives of Neurology|October 15, 2008
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutationsOzlem Goker-Alpan, Grisel Lopez, Joseph Vithayathil, et al.
Expert Opinion on Pharmacotherapy|May 19, 2026
Pharmacotherapies for Gaucher disease: What's New on the horizon?Maya Bhattiprolu, Max Kappler, Tae-Un Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 11, 2021
Comparison of Transcranial Sonography and [<sup>18</sup> F]-Fluorodopa PET Imaging in GBA1 Mutation CarriersDaniel P Eisenberg, Grisel Lopez, Michael D Gregory, et al.
Journal of Movement Disorders|June 13, 2023
Rapid-Onset Dystonia and Parkinsonism in a Patient With Gaucher DiseaseEllen Hertz, Grisel Lopez, Jens Lichtenberg, et al.
Molecular Genetics and Metabolism|October 19, 2021
Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3Emily Daykin, Nicole Fleischer, Magy Abdelwahab, et al.
Frontiers in Neurology|November 4, 2022
Longitudinal evaluation of olfactory function in individuals with Gaucher disease and <i>GBA1</i> mutation carriers with and without Parkinson's diseaseGrisel J Lopez, Jens Lichtenberg, Nahid Tayebi, et al.
American Journal of Medical Genetics. Part A|November 2, 2017
Type 2 Gaucher disease in an infant despite a normal maternal glucocerebrosidase geneErmias Hagege, Richard J Grey, Grisel Lopez, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Expert Opinion on Therapeutic Targets|February 29, 2020
Glucocerebrosidase as a therapeutic target for Parkinson's diseaseYu Chen, Richard Sam, Pankaj Sharma, et al.
Pediatrics|April 2, 2009
Lysosomal storage disorders in the newbornOrna Staretz-Chacham, Tess C Lang, Mary E LaMarca, et al.
Biochemistry|September 28, 2013
Saposin C protects glucocerebrosidase against α-synuclein inhibitionThai Leong Yap, James M Gruschus, Arash Velayati, et al.
Archives of Neurology|October 15, 2008
The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutationsOzlem Goker-Alpan, Grisel Lopez, Joseph Vithayathil, et al.
Expert Opinion on Pharmacotherapy|May 19, 2026
Pharmacotherapies for Gaucher disease: What's New on the horizon?Maya Bhattiprolu, Max Kappler, Tae-Un Han, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 11, 2021
Comparison of Transcranial Sonography and [<sup>18</sup> F]-Fluorodopa PET Imaging in GBA1 Mutation CarriersDaniel P Eisenberg, Grisel Lopez, Michael D Gregory, et al.
Journal of Movement Disorders|June 13, 2023
Rapid-Onset Dystonia and Parkinsonism in a Patient With Gaucher DiseaseEllen Hertz, Grisel Lopez, Jens Lichtenberg, et al.
Molecular Genetics and Metabolism|October 19, 2021
Investigation of a dysmorphic facial phenotype in patients with Gaucher disease types 2 and 3Emily Daykin, Nicole Fleischer, Magy Abdelwahab, et al.
Frontiers in Neurology|November 4, 2022
Longitudinal evaluation of olfactory function in individuals with Gaucher disease and <i>GBA1</i> mutation carriers with and without Parkinson's diseaseGrisel J Lopez, Jens Lichtenberg, Nahid Tayebi, et al.
American Journal of Medical Genetics. Part A|November 2, 2017
Type 2 Gaucher disease in an infant despite a normal maternal glucocerebrosidase geneErmias Hagege, Richard J Grey, Grisel Lopez, et al.
Pageof 17